Educational Blogs

America's Fifth Most Prescribed Drug Was Never Approved for What Most People Take It For

America's Fifth Most Prescribed Drug Was Never Approved for What Most People Take It For

The Failed System  ·  Educational America's Fifth Most Prescribed Drug Was Never Approved for What Most People Take It For Gabapentin was approved in 1993 for seizures. Three dec...

Read more
The Endocannabinoid system and Aging

The Endocannabinoid system and Aging

Your body produces less endocannabinoids as you get older. Phytocannabinoids such as CBD can help fill in the gap.

Read more
5 Ways to Know Your Prescription CBD Platform Is Safe

5 Ways to Know Your Prescription CBD Platform Is Safe

Not all CBD is created equal, and neither is every platform offering it.

Read more
What Is Prescription Cannabinoid Care?

What Is Prescription Cannabinoid Care?

Prescription Cannabinoid Care is a new healthcare category delivering cannabinoid therapy through clinician evaluation, pharmacy compounding, and telehealth. Learn how it works.

Read more
Why Prescription Cannabinoid Care Is Different from Medical Marijuana

Why Prescription Cannabinoid Care Is Different from Medical Marijuana

Prescription Cannabinoid Care uses CBD isolate under physician oversight and pharmacy compounding. Medical marijuana uses THC-containing products through dispensaries. These are structurally differ...

Read more
The Farm Bill, the FDA, and What Comes Next for CBD Patients

The Farm Bill, the FDA, and What Comes Next for CBD Patients

Hemp-derived CBD regulations are actively shifting. Here is what the Farm Bill changes mean for retail CBD users and what the compliant clinical pathway looks like.

Read more
What Is a Compounding Pharmacy and Why It Matters for Cannabinoid Medicine

What Is a Compounding Pharmacy and Why It Matters for Cannabinoid Medicine

A compounding pharmacy prepares individualized medications pursuant to a prescription. Here is how the 503A model works and why it matters for Prescription Cannabinoid Care.

Read more
Why Prescription Cannabinoid Care Exists Now and Not Five Years Ago

Why Prescription Cannabinoid Care Exists Now and Not Five Years Ago

Prescription Cannabinoid Care could not have existed five years ago. Four forces converged to make it possible today: telehealth, compounding infrastructure, patient openness, and regulatory shifts.

Read more
Why Most People Using CBD Are Getting a Fraction of the Dose Ranges Studied in Clinical Research

Why Most People Using CBD Are Getting a Fraction of the Dose Ranges Studied in Clinical Research

A 2021 study found 54% of CBD users take less than 50mg daily. Clinical research has examined dose ranges of 300-400mg. Here is what that gap means.

Read more
What Makes Prescription Cannabinoid Care Different From Retail CBD

What Makes Prescription Cannabinoid Care Different From Retail CBD

Prescription Cannabinoid Care differs from retail CBD in four structural ways: clinical evaluation, prescription pathway, pharmacy compounding, and clinician oversight. Here is how.

Read more
Important safety information

Prescription cannabinoid therapies require clinical oversight.

Common side effects

Prescription cannabinoid therapies may cause drowsiness, fatigue, changes in appetite, diarrhea, and dry mouth. Effects vary by patient, dose, and formulation.

Drug‑interaction risk

CBD can affect how the body metabolizes other medications through cytochrome P450 liver enzymes, which may alter the effectiveness or safety of prescriptions including blood thinners, anti‑seizure medications, and some antidepressants. Disclose all current medications and supplements to your clinician during evaluation.

Liver‑enzyme monitoring

Elevated liver enzymes have been observed in clinical research on CBD, particularly at higher doses. Your clinician may recommend liver‑function testing before or during your protocol. Patients with existing liver conditions require additional review.

Not FDA‑approved

Compounded cannabinoid formulations are prepared under FDA 503A regulations for individual patients. They are not FDA‑approved drugs and have not been evaluated by the FDA for safety, efficacy, or quality in the same way as commercial pharmaceuticals. Compounded medications are prescribed when a clinician determines a commercially available product is not appropriate for a specific patient.

This information is provided for educational purposes and does not replace clinical advice. Speak with a licensed clinician before beginning any cannabinoid protocol. Telehealth currently available in Colorado only. Individual results vary. Prescription decisions are made solely by a licensed clinician and are never automatic.